Moderna president: Corporate outlook 'stabilizing' because of new flu-COVID vaccine information
Moderna (MRNA) is on its method to getting a 3rd mRNA-based vaccine licensed by way of the FDA if the regulatory company likes the information launched Monday for a mix flu-COVID shot.The